This is the official podcast of The Gastroenterology & Hepatology Advanced Practice Providers (GHAPP), an association is dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs). Through our peer-to-peer network, we seek to support their integral role in the specialty healthcare community by providing the most relevant and timely information and communication for the treatment of their patients with gastrointestinal (GI) disorders and chronic liver disease (CLD).
In this three-part miniseries, Elizabeth Goacher, NP, Jeremy Davis, NP, and Allison Moser, NP, discuss emerging treatments for Primary Biliary Cholangitis (PBC). In today's episode, they explore the increasing prevalence, awareness, and identification of PBC, highlighting recent developments in treatment options. The panel reflects on their experiences from the GHAPP 2024 meeting, sharing insights into how enhanced identificat...
In part two of this podcast miniseries, Elizabeth Goacher, NP, Jeremy Davis, NP, and Allison Moser, NP, dive into new therapeutics in the treatment of Primary Biliary Cholangitis (PBC). The panel discusses emerging medications and their dual impact on disease management and symptom relief, including pruritus. Stay tuned for part three for more insights into PBC advancements!
This podcast is supported by an unrestricted edu...
In part three of this miniseries, Elizabeth Goacher, NP, Jeremy Davis, NP, and Allison Moser, NP, discuss key takeaways from the GHAPP National Conference 2024 on Primary Biliary Cholangitis (PBC). They emphasize the shift toward more stringent treatment goals, including the normalization of alkaline phosphatase and bilirubin levels. This new approach marks a significant change from previous guidelines, with the aim of achieving be...
In this KOL Conversation, Renee Pozza, NP, and Allysa Saggese, NP, explore the impact of newly FDA-approved therapies for Primary Biliary Cholangitis (PBC). They highlight the exciting potential of these treatments to improve symptom management, particularly pruritus, while offering enhanced safety profiles and greater flexibility in patient care.
This insightful exchange reflects the evolving landscape of liver disease m...
In this KOL conversation, Jordan Mayberry, PA-C, from UT Southwestern Medical Center, shares insights on managing pruritus in patients with Primary Biliary Cholangitis (PBC). Mayberry discusses the challenges of pruritus as a side effect and the excitement around new, emerging therapies that offer improved management options. He encourages providers to screen for PBC in patients experiencing pruritus now that these treatments are a...
Thank you to Madrigal for sponsoring this Journal Club Video Module!
In this GHAPP Journal Club review, Lisa Richards, a board-certified family nurse practitioner specializing in hepatology at UC San Diego Health, presents pivotal research from a February 2024 New England Journal of Medicine publication. The phase 3 randomized controlled trial evaluated the efficacy of Resmineron, the first FDA-approved therapy for non-alc...
Thank you to Madrigal for sponsoring this FAQ Video Module.
In this GHAPP FAQ Video Module, Corrie Berk, NP, Director of Hepatology and Transplant Outreach Programs at the Texas Liver Institute, explains the liver condition known as MASH, or metabolic dysfunction-associated steatohepatitis, which was previously referred to as NASH. She describes MASH as an inflammatory liver disease caused by excess fat buildup in the live...
Thank you to Madrigal for sponsoring this FAQ Video Module.
In this GHAPP FAQ Video Module, Corrie Berk, NP, Director of Hepatology and Transplant Outreach Programs at the Texas Liver Institute, shares insights on the consequences of untreated metabolic-associated steatohepatitis (MASH) and the importance of early intervention. She discusses how MASH can silently progress to liver failure, liver cancer, and increase cardio...
Thank you to Madrigal for sponsoring this FAQ Video Module.
In this GHAPP FAQ Video Module, Jonathan Yeh, a physician assistant at the Center for Liver Disease and Transplantation at Columbia University Irving Medical Center, discusses advancements in diagnosing and staging metabolic dysfunction-associated steatohepatitis (MASH). He explains the transition from traditional liver biopsy to non-invasive testing methods such ...
Thank you to Madrigal for sponsoring the Medication Review Video Module.
In this GHAPP Medication Review video, Robin Soto, a board-certified nurse practitioner at UC San Diego Health Hepatology, explains the mechanism of action of Resmetirom, the first and only FDA-approved drug for the treatment of MASH in adults with mild to moderate fibrosis (F2-F3). Robin describes how Resmetirom, a liver-directed, thyroid hormone rec...
Thank you to Madrigal for sponsoring this Medication Review Video Module!
In this GHAPP Medication Review Video Module, nurse practitioner Whitney Steinmetz discusses the clinical profile of Resmetirom, a thyroid hormone receptor beta agonist indicated for adults with metabolic-associated steatohepatitis (MASH) and moderate to advanced liver fibrosis. Whitney explores the mechanism of action, dosage recommendations, and th...
Thank you to Madrigal for sponsoring this episode of GHAPPcast.
In this episode of GHAPPcast, nurse practitioners Patrick Horne and April Morris from discuss the complexities of identifying and managing patients with metabolic-associated steatohepatitis (MASH). They explore clinical approaches, including the use of bloodwork, family history, and advanced diagnostic tools such as FibroScan, to recognize patients at risk. P...
Thank you to Ardelyx for sponsoring this FAQ Video Module!
Kim Orleck, GHAPP member and a Physician Assistant at Atlanta Gastroenterology Associates. In this FAQ, Kim shares some of the best practices for accelerating the process of finding the right therapy for IBS-C patients. She emphasizes the importance of using a positive diagnostic strategy to confidently diagnose IBS-C, reducing unnecessary tests, financial strain,...
In this video, Tedra Gray, a Nurse Practitioner, explains what it means for a biosimilar to be interchangeable and why it’s important.
Thank you to Ardelyx for sponsoring this FAQ Video Module!
Join Kim Orleck, GHAPP member, and a Physician Assistant at Atlanta Gastroenterology Associates. In this FAQ, Kim discusses the key resources she uses to stay informed on the latest approaches to managing IBS-C patients. She highlights the importance of guidelines from the ACG and AGA, attending conferences like the GHAPP National Conference and ACG Conference, an...
Thank you to Ardelyx for sponsoring this FAQ Video Module!
Join Kim Orleck, GHAPP member and a practicing Physician Assistant at Atlanta Gastroenterology Associates, on this FAQ video module! Kim shares insights on best practices for determining a clinically meaningful response to therapy for patients with IBS-C. She emphasizes the importance of setting realistic goals, understanding patient symptoms, and using open-ended...
Thank you to Ardelyx for sponsoring this GHAPPcast episode!
In this episode of GHAPPcast, Christina Hanson & Kim Kearns, both seasoned GI & hepatology experts, dive into the pathophysiology, neuromodulation, and patient-centered care for IBS-C (Irritable Bowel Syndrome with Constipation). They discuss the gut-brain interaction and provide practical insights on how to manage IBS-C effectively. From patient educatio...
In this episode of GHAPPcast, host Gabriella McCarty, Nurse Practitioner, is joined by special guest Emily, a patient who shares her firsthand experience with biosimilars.
Listen as they explore the real-world impact of biosimilars, from initial concerns to achieving remission. This episode provides valuable insights into patient perspectives and the role of advanced practice providers in facilitating smooth transitions.
Thank you to Ardelyx for sponsoring this GHAPPcast episode!
In this episode of GHAPPcast, host Christina Hanson, FNP, alongside guest Kim Orleck, PA-C, dives into advanced strategies for diagnosing and managing IBS-C. They discuss the importance of the positive diagnostic strategy, ways to differentiate IBS-C from other conditions, and share valuable insights on how to optimize patient care and treatment. Listeners will g...
Join Nurse Practitioner Tedra Gray as she explains the key differences between biosimilars and generics in gastroenterology.
I’m Jay Shetty host of On Purpose the worlds #1 Mental Health podcast and I’m so grateful you found us. I started this podcast 5 years ago to invite you into conversations and workshops that are designed to help make you happier, healthier and more healed. I believe that when you (yes you) feel seen, heard and understood you’re able to deal with relationship struggles, work challenges and life’s ups and downs with more ease and grace. I interview experts, celebrities, thought leaders and athletes so that we can grow our mindset, build better habits and uncover a side of them we’ve never seen before. New episodes every Monday and Friday. Your support means the world to me and I don’t take it for granted — click the follow button and leave a review to help us spread the love with On Purpose. I can’t wait for you to listen to your first or 500th episode!
Ding dong! Join your culture consultants, Matt Rogers and Bowen Yang, on an unforgettable journey into the beating heart of CULTURE. Alongside sizzling special guests, they GET INTO the hottest pop-culture moments of the day and the formative cultural experiences that turned them into Culturistas. Produced by the Big Money Players Network and iHeartRadio.
The official podcast of comedian Joe Rogan.
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.
If you can never get enough true crime... Congratulations, you’ve found your people.